“…Although it is presently not known whether Epac is required for the development of cardiac hypertrophy or whether its increased expression is a result of hypertrophy, both Epac proteins are upregulated by chronic catecholamine infusion-induced hypertrophy, and only Epac1 is increased in pressure overloadinduced hypertrophy (Ulucan et al, 2007). Transforming growth factor-b 1 (TGF-b 1 ) is a central mediator of fibrogenesis and is involved in the recruitment and activation of (myo)fibroblasts, which may derive from resident mesenchymal cells, circulating fibrocytes, and/or epithelial-to-mesenchymal transition, a process in which epithelial cells transdifferentiate into mesenchymal cells (Schmierer and Hill, 2007;Biernacka et al, 2011;Nieto, 2011;Kovacic et al, 2012;Small, 2012). Loss of Epac1 by TGF-b1 accelerates the deposition of extracellular matrix proteins including collagenIa1, collagenIa2, and collagenIIIa1, and reduces Epac1-dependent migration of fibroblasts from various tissues (including heart, lung, liver, and skin), whereas overexpression of Epac1 attenuates TGF-b1-induced collagen synthesis (Yokoyama et al, 2008c), suggesting that TGF-b1-controlled Epac1 expression modulates tissue homeostasis and fibrogenesis.…”